Response to: "Inhalation NO in the HFNC group may result in a meaningless extension of survival time"
- PMID: 39773495
- PMCID: PMC11707898
- DOI: 10.1186/s13054-024-05218-1
Response to: "Inhalation NO in the HFNC group may result in a meaningless extension of survival time"
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was performed under the exemption criteria from the Mayo Clinic Institutional Review Board. Access to the multicenter Mayo Clinic data was granted through “Viral Infection and Respiratory Illness Universal Study [VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary)” under IRB ID 20–002610. The need for informed consent was waived by the IRB due to its retrospective design, data anonymity, and non-interventional nature. Competing interests: The authors declare no competing interests.
Figures
Comment on
-
Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched study.Crit Care. 2024 Oct 25;28(1):344. doi: 10.1186/s13054-024-05093-w. Crit Care. 2024. PMID: 39456071 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
